Correlation Between Mineralys Therapeutics, and INC Research
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and INC Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and INC Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and INC Research Holdings, you can compare the effects of market volatilities on Mineralys Therapeutics, and INC Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of INC Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and INC Research.
Diversification Opportunities for Mineralys Therapeutics, and INC Research
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and INC is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and INC Research Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INC Research Holdings and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with INC Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INC Research Holdings has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and INC Research go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and INC Research
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.87 times more return on investment than INC Research. However, Mineralys Therapeutics, Common is 1.14 times less risky than INC Research. It trades about -0.05 of its potential returns per unit of risk. INC Research Holdings is currently generating about -0.12 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. INC Research Holdings
Performance |
| Timeline |
| Mineralys Therapeutics, |
| INC Research Holdings |
Mineralys Therapeutics, and INC Research Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and INC Research
The main advantage of trading using opposite Mineralys Therapeutics, and INC Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, INC Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will offset losses from the drop in INC Research's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| INC Research vs. AYR Strategies Class | INC Research vs. Verano Holdings Corp | INC Research vs. TILT Holdings | INC Research vs. Lowell Farms |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |